Eli Lilly and Company LLY GLP1 Oral Market Competition Intensifies As Early Uptake Data Benchmarks Novo Nordisks Oral Wegovy Lead FSI Flexible shares fall 414 after Q4 2025 EPS lands far below analyst consensus estimates USGOW US quarterly earnings metrics are not yet available with investors awaiting fresh operational updates BBLGW Bone Bio quarterly earnings release excludes core financial metrics investors seek additional operational disclosures CFND C1 Fund flags targeted tech sector investments as core strategic priority in latest quarterly earnings update Merck Co Inc MRK Implications of Partner AstraZenecas Q1 2026 Earnings Beat for Oncology Portfolio Trajectory